Top Medical News

FDA Approves Melphalan Flufenamide Combo for Triple-Refractory Myeloma

February 27th 2021

The FDA approved melphalan flufenamide (Pepaxto; melflufen) plus dexamethasone for adults with triple-refractory multiple myeloma.

Overcoming CAR T Resistance in B-Cell Malignancies

February 26th 2021

Up to 50% of patients with B-cell malignancies will relapse on CAR T-cell therapy. Investigators are looking in to new ways to overcome that drug resistance.

Tipifarnib Gets Breakthrough Therapy Designation for HRAS-Mutated HNSCC

February 25th 2021

The FDA has granted a breakthrough therapy designation to tipifarnib for use in patients with recurrent or metastatic HRAS-mutated head and neck squamous cell carcinoma with variant allele frequency of 20% or higher following progressive disease on platinum-based chemotherapy.

APPs Are Key in GU Cancer Care

February 24th 2021

An nurse practitioner discusses how she supports multiple providers in a large academic practice.

FDA Approves Companion Diagnostic for Cemiplimab in Lung Cancer

February 24th 2021

The FDA has approved the PD-L1 IHC 22C3 pharmDx assay, developed by Agilent Technologies Inc, for expanded use in patients with non–small cell lung cancer.


Most Recent